The combination of avutometinib and defactinib in treating recurrent low-grade serous ovarian cancer: a plain language summary of the Phase II clinical trial ENGOT-OV60/GOG-3052/RAMP 201
阿伐替尼联合法伐替尼治疗复发性低级别浆液性卵巢癌:ENGOT-OV60/GOG-3052/RAMP 201 II期临床试验的简明摘要
期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2595130
Banerjee, Susana N; Van Nieuwenhuysen, Els; Aghajanian, Carol; D'Hondt, Véronique; Monk, Bradley J; Clamp, Andrew; Prendergast, Emily; Oaknin, Ana; Ring, Kari; Colombo, Nicoletta; Holloway, Robert W; Rodrigues, Manuel; Chon, Hye Sook; Gourley, Charlie; Santin, Alessandro D; Thaker, Premal H; Gennigens, Christine; Newman, Gregg; Salinas, Erin; Youssoufian, Hagop; Moore, Kathleen N; Lustgarten, Stephanie; O'Malley, David M; Van Gorp, Toon; Grisham, Rachel N